Clinical Trial Update: Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating nafamostat mesilate for efficacy and safety during continuous renal replacement therapy in acute kidney injury has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Nafamostat Mesilate (Nafamostat mesilate)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Acute Kidney Injury | Phase 4 | Status: COMPLETED